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Enquadramento: O teste de marcha com carga progressiva (TMCP) é das 
medidas mais usadas para a avaliação da condição cardiorrespiratória em 
contexto clínico e de investigação. Têm sido estabelecidas equações de referência 
para prever a distância percorrida no TMCP em diferentes populações. No 
entanto, não existe uma equação para adolescentes Portugueses. 
Objetivos: Este estudo teve como objetivo desenvolver uma equação de 
referência para prever a distância do TMCP para adolescentes portugueses. 
Métodos:  Participaram neste estudo transversal adolescentes saudáveis com 
idades compreendidas entre os 12-17 anos. Foram recolhidos dados  sócio-
demográficos (sexo e idade) e antropométricos (índice de massa corporal - IMC) 
dos participantes. A função pulmonar foi avaliada por espirometria e a força 
muscular do quadricípite (FMQ) foi medida com dinamometria manual digital. O 
nível de atividade física foi avaliado com o Índice de Atividade Física (IAF). O 
TMCP foi realizado duas vezes, de acordo com as recomendações internacionais. 
A melhor performance foi utilizada para análise descritiva e inferencial. 
Resultados: Um total de 125 participantes (56 masculino, 69 feminino; 14,6±1,3 
anos de idade) com função pulmonar normal (volume expiratório máximo no 
primeiro segundo=104.8±14.9% previsto) completaram a avaliação. De acordo 
com a pontuação do IAF, 54.4% (n=63) dos participantes eram moderadamente 
ativos e a média da FMQ foi de 20.7±6.8 kgf. Os participantes percorreram em 
média 1254.0±280.9 (760-2250) metros no TMCP. Um modelo de regressão linear 
múltipla mostrou que o sexo, IMC, FMQ e IAF contribuem independentemente 
para o TMCP, explicando 54% da sua variabilidade (p<0.05). A equação de 
referência encontrada foi: TMCP= 814.49 + (286.80 x sexo) - (3.05 × IMC) + (8.83 
× FMQ) + (22.30 × IAF), sexo: feminino = 0, masculino = 1. 
Conclusão: Sexo, IMC, FMQ e IAF integraram a equação preditiva do TMCP para 
adolescentes, permitindo uma referência simples para prever a sua condição 
cardiorrespiratória. A equação preditiva é uma ferramenta valiosa para 
interpretar os resultados do TMCP em populações pediátricas, saudáveis ou com 
patologia. 
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Background: The incremental shuttle walk test (ISWT) is one of the most used 
measures to assess cardiorespiratory fitness in clinical and research settings. 
Reference equations to predict ISWT distance (ISWD) in different populations 
have been established. However, an equation for Portuguese adolescents is not 
available. 
Aim: This study aimed at developing a reference equation to predict the ISWD for 
Portuguese adolescents. 
Methods: Healthy adolescents aged 12–17 years old participated in this cross-
sectional study. Participants’ socio-demographic (sex and age) and 
anthropometric (body mass index (BMI)) data were collected. Lung function was 
assessed through spirometry and quadriceps muscular strength (QMS) was 
recorded with a hand-held dynamometer. Physical activity level was scored with 
Physical Activity Index (PAI). The ISWT was performed twice as recommended. 
The best ISWD was used for descriptive and inferential analysis. 
Results: A total of 125 (56 male, 69 female; age 14.6±1.3 years old) participants 
with normal lung function (forced expiratory volume in one second=104.8±14.9% 
predicted) completed the assessment. According to PAI score, 54.4% (n=63) of the 
participants were moderately active and QMS mean was 20.7±6.8 kgf. Participants 
walked on average 1254.0±280.9 (760–2250 m) meters in the ISWT. A multiple 
regression model showed that sex, BMI, QMS and PAI were independent 
contributors to the ISWD, explaining 54% of the variability (p<0.05). The derived 
reference equation was: ISWD= 814.49 + (286.80 × sex) - (3.05 × BMI) + (8.83 × 
QMS) + (22.30 × PAI), sex: female=0, male=1. 
Conclusion: Sex, BMI, QMS and PAI score were found to be contributors to the 
ISWD predictive equation for adolescents, providing a simple reference to assess 
their cardiorespiratory fitness. The predictive equation is a valuable tool to 
interpret ISWT results obtained from paediatric populations, both healthy and 
with pathology. 
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1. Introduction 
Evaluation of exercise capacity and cardiorespiratory fitness (CRF) is a common practice in 
preventive and rehabilitative exercise programmes to establish prognosis and response to 
treatment (1). 
Laboratory tests, such as cardiopulmonary exercise test (CPET), are largely recognised as the 
gold standard to assess CRF (1). However, in routine clinical practice, they can be unviable (2–
4), due to the high cost involved, the need for sophisticated equipment and human resources 
(5). Quite the reverse, field tests require minimal equipment and are easy to perform (6). The 
time- and distance-limited tests to assess walking capacity are quick to apply, simple and can 
be administered in both clinical and research settings (7). The incremental shuttle walk test 
(ISWT) is among the most used field tests (8) to evaluate exercise capacity. 
The ISWT was designed by Singh and colleagues (9) based on the 20 metre shuttle run test (10) 
to assess functional exercise capacity of patients with chronic obstructive pulmonary disease 
(COPD). The objective of this field test is to walk as long as possible in a 10 metre length course, 
maintaining the speed required by the audio signals (11). The test is defined as an externally 
paced maximal exercise test, ordered by a series of pre-recorded signals, and incremental, in 
which the walking speed increases until the participant can no longer continue (9). 
The incremental nature of the ISWT stresses the cardiopulmonary system and generates a 
physiological response to exercise (12), replicating, in the field, a similar response as a CPET 
(11). Previous validation studies in populations with COPD showed a strong relationship 
between oxygen uptake (VO2) in both CPET and ISWT (r from 0.75 to 0.88) (13–16). Moreover, 
there was no difference in measured VO2 between CPET and ISWT (5,17,18). Physiological 
parameters, such as carbon dioxide production and minute ventilation, are usually lower 
during the ISWT performance (19). A peak oxygen uptake (VO2peak) minute-by-minute analysis 
verified a linear response between ISWT and CPET (5). This  indicates that both tests generate 
a similar cardiopulmonary response (19). Recent literature suggests that the ISWT is a valid 
measure of cardiopulmonary exercise capacity in populations with COPD (19). A study on its 
reliability has also been conducted in patients with COPD (n=30) and reported an intraclass 
correlation coefficient of 0.88 with a 95% CI of 0.83–0.92 (20). The minimal important 
difference (MID) for ISWT, in adults with chronic respiratory diseases is a change of 47.5 
meters (19). 
The ISWT has been largely used to assess exercise capacity in patients with COPD (21–25). 
However, it has also been applied in other adult populations with bronchiectasis (3,26), cancer 
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(27–29), cardiac disease (4,30–34), critical illness (35), cystic fibrosis (36), intellectual 
disabilities (37), interstitial lung disease (38), obesity (39) and pulmonary hypertension (40). 
Yet, in younger populations, ISWT has only been used in healthy and with cystic fibrosis 
children (41) or with cerebral palsy (42). Nonetheless, references values are needed to 
interpret the ISWT performance in paediatric populations. 
Recently, reference values and regression equations for predicting ISWT distances in adult 
healthy individuals from 18 to 90 years have been published (8,12,43–45). In paediatrics, only 
one study has published preliminary ISWT reference values for the Brazilian population (46). 
For the Portuguese population, an academic work (non published) has recently contributed for 
the development of a paediatric predictive equation (47). Although commonly used in adults, 
the ISWT is less explored as a tool for assessment of exercise capacity in paediatric population. 
However, given its advantages a paediatric reference equation to predict the distance may 
contribute to overcome this gap in literature. 
Therefore, the aim of this study was to establish an ISWT reference equation for the Portuguese 
healthy adolescent population.  
 
2. Methods 
2.1. Ethics 
Ethical approval was previously obtained from the Ethics Committee of the Research Unit of 
Health Sciences at the School of Nursing in Coimbra, Portugal (P 246-12/2014) (Annex I). 
Further authorisations to apply the study were requested and obtained from School Boards of 
two schools in Aveiro, Portugal (Annex II). Prior to any data collection, written informed 
consents were obtained from adolescents and their legal representatives (48). 
2.2. Design and Participants 
A cross-sectional study was conducted. Two schools from the region of Aveiro were contacted 
and both accepted to participate. Each school director nominated a responsible from the school 
board to assist with the study implementation. A meeting was then arranged with each 
responsible to provide further explanations and deliver written information about the study 
(Appendix I) as well as distribute informed consents (Appendix II). 
Adolescents were eligible if: i) aged 12 to 17 years old; ii) provided their informed consent and 
iii) presented an informed consent form signed by the legal representative. Exclusion criteria 
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included: i) existence of neurological impairment or significant cardiopulmonary and/or 
musculoskeletal disorders and ii) any other significant contraindication that could affect 
physical tests performance, such as visual or hearing impairments. 
2.3. Procedures 
Socio-demographic, clinical and anthropometric data were first collected to characterise the 
sample. A questionnaire to evaluate the level of physical activity was filled in. A spirometry was 
performed to ensure normal lung function. Then, quadriceps muscle strength (QMS) was 
measured. Finally, two ISWTs were performed with, at least, 30 minutes of resting between 
them, as recommended (3,45). 
2.4. Measures 
A structured questionnaire was used to collect socio-demographic (sex and age), general 
clinical information (medication, exposure to environmental risk factors and clinical history), 
anthropometric data (weight and height to calculate body mass index (BMI) percentile) and 
physical activity level to characterise the sample. 
Weight (in kilos) and height (in centimetres) were assessed, with participants in underwear 
and barefoot, using a Jofre® mechanical weight and height counter scale, to the nearest 0,1 kg 
and 0,5 cm, respectively. For children and adolescents (5-19 years old), BMI is age- and sex-
specific and is frequently referred to as BMI-for-age (49). Percentiles are the most frequently 
used indicator to assess size and growth patterns of individual children and adolescents (49). 
In order to accurately determine the BMI percentile of each participant, an application tool 
available in the World Health Organization website 
(http://www.who.int/growthref/tools/en/), with an anthropometric calculator, was used 
(50). All BMI referred in this study are age- and sex-specific and will be mentioned as BMI. The 
percentile ranges correspond to a weight status category: less than the 5th percentile–
underweight, 5th percentile to less than the 85th percentile–healthy weight, 85th to less than 
the 95th percentile–overweight and equal to or greater than the 95th percentile–obese (49). 
The physical activity level was collected using the Physical Activity Index (PAI) (51). The PAI 
is composed of 5 questions and answers are scored from 1 to 4 points. Final score ranges from 
5 to 20 points, in which high values indicate a higher physical activity level, and can be divided 
in 4 categories: 5 sedentary, 5–10 low active, 10–15 moderately active and 15–20 vigorously 
active (51). This questionnaire has been validated to the Portuguese population (51,52), 
demonstrating excellent values of test-retest reliability (intraclass correlation 
coefficient=0.92–0.96) and good internal consistency (Cronbach’s alpha=0.87) (52). 
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Lung function was assessed with a spirometric test performed as described by Miller et al (53), 
to ensure normal lung function of all participants. Spirometry is a simple and non-invasive test 
and is indicated to assess health status before vigorous physical activity exercise to identify the 
presence of restrictive or obstructive respiratory abnormalities (1). The most frequently 
measurements considered in spirometry include the forced vital capacity (FVC), forced 
expiratory volume in one second (FEV1) and FEV1/FVC ratio (1). Spirometry was performed 
before the ISWTs using a portable spirometer (MicroLab 3500, CareFusion, Kent, UK). The 
participant was encouraged to execute a maximal inspiration, then a blast of exhalation and 
maintain the exhalation until completely breathing out (53). The best out of three tests was 
considered (53). 
Hand held dynamometry allows the assessment of muscular strength, is easy to use and only 
requires a portable and compact size equipment (54). Muscle strength is a parameter to 
determine the presence of pathological muscle weakness or to evaluate the efficacy of an 
intervention (55). Quadriceps muscular strength was assessed with a hand held dynamometer 
(Hoggan MicroFET2 Muscle Tester, Model 7477, Pro Med Products, Atlanta, GA), in kilogram of 
force (kgf). Participants were sitting on a chair, with the knee flexed 90°, hip flexed 90° and 
straight trunk. The hand held dynamometer was placed in the anterior surface of the dominant 
leg, proximal to the ankle (5 cm above lateral malleolus). The participant performed at least 
one practice trial to understand the movement and the adequate stabilisation. Then, two trials 
were performed with a ten seconds contraction followed by a sixty second rest period. The 
mean of the values acquired was considered for analysis (56). 
Incremental shuttle walk test protocol was applied as described by Singh et al (9) and Probst 
et al (45). This is an externally paced maximal exercise test, controlled by pre-recorded signals 
that command the walking speed (43). The walking speed increases 0.17m/s each minute, 
starting at 0.5m/s, until the participant can no longer carry on with the test. The audio signals 
continued until subjects reach their maximal effort, exceeding the 12 levels of speed 
recommended by Singh et al (9) protocol (45). This proposed adaptation was needed to avoid 
a ceiling effect, considering that participants were healthy and could possibly reach more than 
the 12th level to get their maximal performance(45). The ISWT is a valid and reliable test when 
assessing maximal exercise capacity in individuals with chronic respiratory diseases (19,57). 
Previous research showed that ISWT is a reproducible and valid measure to assess the 
function-limited aerobic capacity also in children with cystic fibrosis (6 to 16 years) (58). A 
brief standard explanation about the test was previously provided by an audio record (11). 
Participants were instructed to walk or run if necessary between the two markers (Figure 1) 
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in time ordered by audio signals, for as long as possible until being too breathless or could not 
perform the distance within the beep time in two consecutive times. The ISWT was performed 
twice for the learning effect and the best result was considered for analysis (6,19). Thirty 
minutes of rest were allowed between the two tests. The distance (in meters), the level and the 
number of shuttles achieved were recorded. The reason to end the test was also registered. 
 
Figure 1 Course layout scheme for the ISWT. Cones are inset 0.5 m from either end (Adapted from (11)). 
 
To ensure participants’ safety, physiological responses to ISWT performance such as dyspnoea, 
fatigue, heart rate, peripheral oxygen saturation, arterial blood pressure and respiratory rate 
(RR) were monitored before and after the two ISWTs, in sitting position (1). Dyspnoea and 
fatigue were measured with the modified Borg Scale (mBS), due to the good correlation with 
the VO2peak (59). The mBS ranges from 0–10 points, where 0 means no difficulty at all and 10 a 
maximal difficulty in either breathing or fatigue (60,61). The heart rate and peripheral oxygen 
saturation were measured by a pulse oximeter (PULSOX-300i, Konica Minolta Sensing, Inc., 
Osaka, Japan) in the non-dominant hand indicator and arterial blood pressure with a blood 
pressure monitor (Elite, Medel, Parma, Italy). Arterial blood pressure was measured at heart 
level in the left harm, with the participant in sitting position; harm and hand were relaxed and 
supported by a table (1). Respiratory rate was measured through clinical observation, in 15 
seconds intervals and then multiplied by 4, to determine the number of respiratory cycles for 
1 minute (20). 
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2.5. Data Analysis 
Data were analysed using IBM SPSS Statistics version 22 (SPSS Inc., Chicago, Illinois, IL). 
Descriptive statistics was first applied to characterise the sample (i.e., socio-demographic and 
anthropometric data, PAI score, lung function and QMS and the best performance of ISWT (i.e., 
distance, number of shuttles, level and physiological responses). Data were described as 
mean±standard deviation (SD) or as frequencies. The predicted maximal heart rate (HR max. 
pred.) for each participant was calculated according to the formula 206.9 - (0.67 × age) (62) as 
well as the percentage of the HR max. pred. achieved in the end of the test. The normality of data 
distribution was confirmed with Shapiro-Wilk tests (63). 
Pearson correlation coefficients (r) were used to measure the strength of association between 
continuous variables (age, weight, height, BMI, HR max. prev., QMS and FEV1%) and incremental 
shuttle walk distance (ISWD). The point-biserial correlation coefficient (rpb) is a special case of 
Pearson correlation in which one variable is dichotomous and nominal (sex) and the other 
variable is quantitative (ISWD) (64). The value of the correlation coefficient, for both Pearson 
and point-biserial coefficients, varies between +1 and -1. If the value of the correlation 
coefficient lies around ±1, a strong association between the two variables is confirmed. As the 
correlation coefficient value goes towards 0, the relationship between the two variables is 
weaker. Correlation can be categorised in accordance with absolute value of r or rpb: ≤0.35 
weak correlation; 0.36–0.67 modest correlation; 0.68–1.0 strong correlation; ≥0.90 very high 
correlation (65). 
A model of multiple linear regression, using the Enter mode, was applied to estimate the best 
predictor model for ISWT distance. ISWD was the dependent variable and demographic and 
anthropometric data, PAI score and QMS were the independent variables. The assumptions of 
linearity, independence of errors, homoscedasticity, unusual points and normality of residuals 
were analysed. ANOVA and R-squared (R2) were used to assess the performance of the model. 
Measured ISWDs were compared with the values obtained with the predicted equation 
proposed in the present study and with other two predictive equations from Silva (47) and 
Lanza et al. (46) using paired-samples t-tests. Correlations were also explored with Pearson 
correlation coefficients. 
The level of significance considered was set at p<0.05. 
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3. Results 
 
3.1. Participants’ characteristics 
A total of 125 healthy participants (56 male and 69 female) completed the assessment. 
Participants’ detailed characterisation is summarised in Table 1. Participants’ mean age was 
14.6±1.3 years old. Most participants had a normal BMI (n=102; 81.6%) and lung function 
(FEV1 104.8±14.9% predicted) according to their age and sex. Based on the PAI score, 54.4% 
of the participants (n=63) were moderately active. 
 
Table 1 Characteristics of the sample (n=125). 
Characteristics Value 
Male/Female 56/69 
Age (years) 14.6 ± 1.3  (12 – 17)  
Weight (kg) 55.9 ± 11.7  (32 – 99) 
Height (m) 1.6 ± 0.1  (1.4 – 1.9) 
BMI-for-age (percentile) 50.3 ± 28.44 (0.2 – 99.1) 
PAI score 12.9 ± 3.4  (5 – 19) 
FEV1 predicted (%)  104.8 ± 14.9  (55 – 135) 
FVC predicted (%) 98.6 ± 13.2  (51 – 125) 
FEV1/FVC (%)  94.1 ± 8.9  (79 – 118) 
QMS (kgf) 20.7 ± 6.8  (7.1 – 34.0) 
Data are presented as mean ± SD (range), unless otherwise indicated. 
BMI: body mass index; FEV1: forced expiratory volume in one second; FVC: forced vital 
capacity; PAI: Physical Activity Index; QMS: quadriceps muscular strength. 
 
 
3.2. Characterisation of the ISWT 
Table 2 presents the outcomes of the best performance on the ISWT and the respective 
physiological responses. The mean ISWD was 1254.0±280.9 meters. The mean number of 
shuttles performed was 125.4±28.1 and the level achieved 13.9±1.7. 
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Table 2 Outcomes of the Incremental Shuttle Walk Test (n=125). 
Parameters Mean ± SD (range) 
Distance (m) 1254.0 ± 280.9 (760 – 2250) 
Number of Shuttles 125.4 ± 28.1 (76 – 225) 
Level 13.9 ± 1.7 (11 – 19) 
Pre Dyspnoea 0.2 ± 0.5 (0 – 3)  
Post Dyspnoea 5.8 ± 2.3 (0 – 10) 
Pre Fatigue 0.3 ± 0.9 (0 – 5) 
Post Fatigue 6.6 ± 2.1 (0 – 10) 
Pre HR (bpm) 79.7 ± 13.7 (48 – 110) 
Post HR (bpm) 132.7 ± 35.4 (65 – 207) 
HR max.  pred. (bpm) 197.1 ± 0.9 (195.5 – 198.9) 
% HR max.  end. (%) 67.3 ± 18.0 (33.0 – 105.5) 
Pre SpO2 (%) 97.5 ± 2.4 (84 – 100) 
Post SpO2 (%) 95.8 ± 3.0 (83 – 100) 
BP: blood pressure; HR: heart rate; RR: respiratory rate; SpO2: peripheral oxygen saturation; % HR max.  end.: 
percentage of HR achieved in the end of the test. 
 
 
3.3. Associations with ISWD 
Table 3 presents the correlations between the ISWD and several variables collected within this 
study. There was no correlation between the ISWD and age, weight, HR max. pred. or FEV1, p > 0.05. 
Correlations were weak between the ISWD and height (r=0.30) and BMI (r=-0.20); and 
moderate between the ISWD and sex (r=0.53), PAI score (r=0.40) and QMS (r=0.38). 
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Table 3 Pearson Correlation Coefficients between ISWD and its determinants. 
 r p-value 
Sex 0.53 <0.001 
Age (years) 0.06 0.497 
Weight (kg) 0.00 1.000 
Height (m) 0.30 0.001 
BMI-for-age (percentile) -0.20 0.029 
FEV1 (%) 0.07 0.497 
HR max. pred. (bpm) -0.61 0.497 
PAI score 0.40 <0.001 
QMS (kgf) 0.38 <0.001 
BMI: body mass index; FEV1: forced expiratory volume in one second; HR max. pred.: heart 
rate maximum predicted; PAI: Physical Activity Index; QMS: quadriceps muscular 
strength. 
 
 
3.4. ISWD predictive equation 
The assumptions of linearity, independence of errors, homoscedasticity, unusual points and 
normality of residuals were verified. A multiple linear regression was run to predict ISWD from 
sex, BMI, PAI score and QMS. These four variables were statistically significant predictors of 
the ISWD (ANOVA p<0.001) and together explained 54% of their variability (R2=0.54). 
Unstandardised regression coefficients (B), standard errors of the coefficients and 
standardised coefficients (β) are presented in Table 4. 
 
Table 4 Summary of multiple regression analysis for ISWT distance as dependent variable. 
Variable B (95% CI) Std. Error β p-value 
(Constant) 814.49 (628.65 – 1000.33) 93.62   <0.001 
Sex 286.80 (202.55 – 371.05) 42.44 0.48 <0.001 
BMI-for-age (percentile) -3.05 (-4.46 – -1.64) 0.71 -0.30 <0.001 
PAI score 22.30 (10.67 – 33.93) 5.86 0.27 <0.001 
QMS (kgf) 8.83 (2.60 – 15.07) 3.14 0.21 0.006 
BMI: body mass index; PAI: Physical Activity Index; QMS: quadriceps muscular strength. 
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Based on the multiple linear regression model, the equation to predict ISWD from sex, BMI, PAI 
score and QMS was: 
ISWD= 814.49 + (286.80 × sex) - (3.05 × BMI) + (8.83 × QMS) + (22.30 × PAI), sex: female=0, 
male=1. 
BMI: body mass index; PAI: Physical Activity Index score; QMS: quadriceps muscular strength. 
 
 
3.5. Comparisons with other predictive equations 
Paired-samples t-test showed that the ISWDs measured and the predictive ISWDs obtained 
from the proposed equation of this study were not significantly different (mean difference 
26.9±219.9m; p=0.174) (Erro! A origem da referência não foi encontrada.). Nevertheless, 
the ISWDs measured in the present study and the predictive ISWDs from Silva (47) (mean 
difference 232.2±274.3 m; p<0.001) and from Lanza et al. (46) (124.4±281.3m; p<0.001) were, 
however, significantly different. ISWDs achieved in this study were higher (1254.0±25.1m), 
than the predicted from the equations from Silva (47)( 1221.8±19.9 m) and Lanza et al. (46)( 
1129.6±3.6 m). 
 
Table 5 Summary of the Paired-samples t-test between the ISWDs and other two predictive equations. 
Paired-samples Mean difference (95% CI) Std. Deviation p-value 
Actual ISWDs – Present study’s equation 26.9 (-12.013 – 65.853) 219.9 0.174 
Actual ISWDs – Silva’s equation (47) 232.2 (183.7 – 280.8) 274.3 <0.001 
Actual ISWDs – Lanza’s et al. equation (46) 124.4 (74.6 – 174.2) 281.3 <0.001 
ISWDs: distances performed in the ISWT by the participants in the present study 
 
Modest correlations were found between the ISWDs measured in the present study and the 
predicted values with the equation proposed in this study (r=0.64; p<0.001) and the equation 
established by Silva (47) (r=0.43; p<0.001). The correlation between the ISWDs measured in 
the present study and the predicted values with the equation from Lanza et al. (46) was weak 
and not statistically significant (r=0.06; p=0.497). These correlations are shown in Figure 2. 
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Figure 2 Scatterplots of the correlations between the ISWDs performed and the predicted ISWDs from the equations 
proposed (A) in this study, (B) by Silva (47) and (C) by Lanza et al. (46). 
 
4. Discussion 
The present study established a predictive equation for ISWT distance in healthy adolescents. 
The predictive equation included sex, BMI, QMS and PAI score as independent variables. 
Results of the present study demonstrated that the mean ISWT distance for healthy 
adolescents aged 12–17 years old was 1254.0±280.9 meters, with a large variability (760–
2250 meters). This variability can be explained by different demographic and anthropometric 
variables such as sex, height and body weight, muscular strength condition and physical 
activity levels. Large variability in ISWD has also been reported due to similar reasons, in a 
study with healthy adults aged 18–83 years old (45). 
A regression equation was established using contributors such as sex, BMI, QMS and PAI score. 
These independent variables explained 54% of the ISWT variance. Recent literature reported 
similar R2 values in predictive equations for ISWD in healthy adults; one study using age, 
height, weight and sex (R2=71%) (45) and the other using age, BMI, FEV1, quadriceps muscular 
voluntary contraction and an activity status index (R2=50%) (43). Previous studies, with 
different samples, (8,12,44,45), support the integration of sex in predictive equations for ISWD. 
The negative weak correlation observed between ISWD and BMI means that, for higher values 
of BMI, the distance covered in the ISWT was smaller. This may be related to the effort required 
to perform the walking test due to higher participants’ weight. Kantanista (66) and colleagues 
suggested a relationship between the increase of body fat in the adolescence and the lower 
levels of physical activity. Besides socio-demographic and anthropometric variables, muscular 
strength was also considered, through the QMS and a moderate correlation (r=0.38) with ISWT 
distance was observed. Recently, Harrison (43) has also measured additional variables, which 
have not been considered previously, such as quadriceps muscular voluntary force, to explain 
a greater percentage of the variance of a predictive equation in healthy individuals. This 
relationship had already been proposed by  Steiner (67) in a study with patients with COPD.  
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A good correlation has also been observed between ISWD and PAI score (r=0.40) suggesting 
that a higher PAI score indicates a better physical fitness and consequently a better 
performance in the walk test. This relationship was expected considering that it was reported 
in prior study with adult population. (43). The variables with higher correlations with the 
ISWD also had a higher contribution in the predictive equation for ISWD, with higher 
regression coefficients: sex with 286.80 and PAI score with 22.30. Other studies also showed 
sex as the strongest predictor in their equations (44,45). In the present study, variables with 
weak correlations with ISWD, such as QMS and BMI, also had weak contributions in the 
predictive equation. 
Recently, a research group published preliminary results for a reference equation for the ISWD 
in Brazilian children (mean age 8±1 years), using age as independent variable, with a low 
coefficient of variation (R2=13%) (46). When applying their equation to the sample of the 
present study, the actual distance performed was greatly underestimated. This may be due to 
the different age-range used, since the sample of the present study was composed of 
adolescents (12-17 years old), whereas the Lanza and colleagues study (46) included children 
(mean age 8 years old). The specific anthropometric characteristics, such weight and height, of 
children can also justify the verified underestimation. This underestimation was not observed 
when the equation established in this study was used. In addition, other comparison was 
performed with a predictive equation for the ISWD, which included the variables sex, age, 
weight and QMS, in Portuguese children aged 5–17 years old (47). This equation also 
underestimated the predictive distance for ISWT. Although both samples are from paediatric 
Portuguese population, they refer to different age ranges, with specific anthropometric 
characteristics and physical activity levels. This highlights the need and importance of 
establishing reference equations adapted to socio-demographic, anthropometric and cultural 
contexts of the population, which can be easily applied in clinical and research settings. 
As supported by Jürgensen (44), reference equations are valuable tools for evaluating ISWT 
results obtained from patients with chronic diseases as much as in other populations, 
considering the external paced nature of the walk test and the inexistence of interference of 
external factors, such as operator encouragement. This emphasises the application of 
predictive equations established for healthy individuals as well as to individuals with any 
condition. Other motivation to establish reference equations is the simplicity to predict the 
ISWD to any adolescent without having to perform the ISWT, requiring simple measures 
obtained in clinical practice. This allows physiotherapists to prescribe individualised aerobic 
exercises and adequate levels of physical activity to adolescents’ physical condition, as well as 
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its adjustment when necessary. Other use to the predictive equations is to follow the evolution 
in rehabilitation programmes and easily compare healthy and other conditions’ populations.  
Some limitations of this study should be considered. As observed in other studies, it was 
expected that age influenced the model of the predictive ISWD equation, which did not occur. 
This may be due to the low variability in the age range considered in this study (12–17 years 
old). In previous investigations, age was retained in the predictive model, with samples with 
larger age variability (8,12,44,45). The obtained coefficient of determination was modest 
(54%), increasing the chance of bias in predicting the walking distance in the ISWT. This 
finding confines the generalisation of the predictive equation to the Portuguese adolescents’ 
population. In future research, it is recommended that this protocol is replicated with a larger 
sample. Other recommendation to strengthen the predictive model equation found and to 
generalise it, is to add samples of adolescents from different regions of the country. In 
alternative to the mathematical multiple linear regression model used in the present study, it 
might be interesting to compare it with an artificial neural network-based equation model. This 
mathematical model is based on some properties of the biological nervous system and on the 
analogies of adaptive biological learning (68). This method uses a networks’ combination of 
the inputs and the learning effect to find the best functional fit for a set of input-output 
examples (69). 
 
5. Conclusions 
This study established a predictive equation for ISWT distance, where Sex, BMI, QMS and PAI 
score were major contributors, accounting for 54% of the variability of the ISWD. This 
predictive equation is a valuable tool to interpret ISWT results obtained from paediatric 
populations, both healthy and with chronic diseases. Furthermore, this predictive equation can 
be used to support the design of interventions for healthy adolescents and adolescents with 
impaired exercise capacity or with chronic diseases. 
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Escola Superior de Saúde da Universidade de Aveiro 
 
 
Folha de Informação ao Encarregado de Educação 
 
As investigadoras Joana Batista de Castro Pinto e Tânia Maria Pereira de Pinho, a frequentar o Mestrado 
em Fisioterapia da Escola Superior de Saúde da Universidade de Aveiro, sob a orientação científica da 
Professora Doutora Alda Sofia Pires de Dias Marques, vêm por este meio solicitar-lhe a autorização para 
a participação do seu educando no estudo clínico intitulado: “Caracterização e estabelecimento de 
valores normativos de condição física em adolescentes”. 
 
Mas, antes de decidir, é importante que compreenda porque é que a investigação está a ser realizada e o 
que é que a mesma envolve. Por favor, leia a informação com atenção e discuta a participação do seu 
educando, com outros se assim o entender. Se houver algo que não esteja claro para si ou necessitar de 
informação adicional, por favor não hesite em contactar a aluna ou a sua orientadora (contactos no final 
deste documento). 
 
Muito obrigado desde já por ler a informação. 
 
 
Qual é o propósito do estudo? 
Este estudo visa estabelecer valores de referência para a condição física em crianças com patologia 
respiratória e saudáveis (12-17 anos). Estes testes permitem uma avaliação objetiva e segura da 
condição física de adolescentes sendo por isso largamente utilizados pelos fisioterapeutas para 
prescrever exercício físico em adolescentes com várias patologias como por exemplo, com asma, fibrose 
cística, patologia oncológica ou condições neuromusculares. No entanto, ainda não se encontram 
estabelecidos valores de referência que permitam diferenciar com segurança a normalidade das 
condições patológicas. Para que seja possível determinar estes valores de referência, vimos então 
solicitar-lhe autorização para que o seu educando participe neste estudo que será realizado na 
instituição de educação por ele frequentada. 
 
Porque foi o meu educando escolhido? 
O seu educando foi escolhido porque: 
 se encontra a frequentar uma escola do distrito de Aveiro que deu permissão institucional para 
a realização do estudo,  
 não apresenta qualquer tipo de contra-indicação à participação no mesmo. 
Escola Superior de Saúde da Universidade de Aveiro 
 
 
Tenho de aceitar a participação do meu educando? 
A decisão de autorizar a participação do seu educando ou não é completamente sua. Se decidir autorizar 
vai-lhe ser pedido que assine dois consentimentos informados, um para si e outro para as investigadoras. 
No entanto, é totalmente livre de desistir a qualquer momento, sem que para tal tenha de dar qualquer 
justificação. A decisão de desistir ou de não participar, não afetará a qualidade dos serviços de educação, 
ou quaisquer outros, prestados ao seu educando agora ou no futuro. 
 
O que acontecerá se autorizar a participação do meu educando? 
Se decidir participar vai-lhe ser pedido que preencha o documento anexo a esta folha de informação 
relativamente à saúde do seu educando e que o entregue, bem como o consentimento informado, ao 
docente que entrou em contacto consigo. 
Após receber o consentimento informado devidamente assinado, as alunas dirigir-se-ão à instituição de 
educação do seu educando e procederão à recolha de algumas medidas muito simples como o peso e a 
altura, e testes para avaliar a sua condição física. Estes testes consistem em avaliar a composição 
corporal, a força muscular, a flexibilidade, condição neuromuscular e a função cardiorrespiratória. Ser-
lhe-á também pedido que responda a um questionário para avaliar as atividades físicas que o seu 
educando realiza dentro e fora da instituição. 
A aplicação do protocolo terá a duração de aproximadamente 40 minutos e será realizado em horários 
compatíveis com as atividades educacionais, de forma a não afetar o programa letivo de atividades. 
 
Quais são os efeitos secundários dos procedimentos do estudo? 
Não existem efeitos secundários de participar no estudo. 
 
Quais são as possíveis desvantagens e riscos se resolver autorizar a participação do meu 
educando? 
Não existem quaisquer desvantagens ou riscos de participar no estudo. 
 
Quais são os possíveis benefícios se eu resolver autorizar a participação do meu educando? 
Não existem benefícios diretos de participar no estudo. No entanto, todas as medidas recolhidas na 
avaliação ser-lhe-ão comunicadas para que fique informado acerca do estado de saúde e físico do seu 
educando. Para além disso, a informação obtida neste estudo poderá ajudar a desenvolver valores de 
referência para testes largamente utilizados na fisioterapia, permitindo uma melhor avaliação e 
monitorização de adolescentes. 
Escola Superior de Saúde da Universidade de Aveiro 
 
 
A participação será confidencial? 
Toda a informação recolhida no decurso do estudo será mantida estritamente confidencial. Os dados 
recolhidos serão salvaguardados com um código, para que ninguém os possa identificar. Apenas as 
alunas responsáveis pelo projeto e a sua orientadora terão acesso aos dados.  
 
O que acontecerá aos resultados do estudo? 
Os resultados do estudo serão analisados e incorporados em dissertações de Mestrado e alguns serão 
publicados em Jornais e/ou conferências de finalidade científica. No entanto, em nenhum momento o 
seu educando será identificado. Se pretender obter uma cópia de qualquer relatório ou publicação, por 
favor solicite-o enviando e-mail para as alunas responsáveis pelo projeto. 
  
 
Contacto para mais informações sobre o estudo 
Se pretender obter mais informações sobre o estudo, pode telefonar ou escrever para: 
Joana Pinto, Tânia Pinho e Alda Marques 
Escola Superior de Saúde da Universidade de Aveiro,  
Universidade de Aveiro,  
Campus de Santiago,  
Edifício III, 3810-193, Aveiro  
Telefone: 234 247 113 ou 234 372 462 
e-mail: pinto.joana@ua.pt; taniamariapinho@ua.pt; amarques@ua.pt 
 
Muito obrigado por ter lido esta informação. 
 
___________________________________________________________________________________________________________________ 
 
Se pretender obter uma cópia de qualquer relatório ou publicação, por favor indique o seu contacto 
de e-mail no espaço seguinte: _________________________________________________________________________________ 
 
 
  
 
Appendix II – Informed Consent 
  
Consentimento Informado 
 
Título do Projeto: Promoção da atividade física pediátrica através da monitorização e feedback de uma 
aplicação de smartphone 
 
Orientadora: Prof. Doutora Alda Sofia Pires de Dias Marques 
Alunas de Mestrado: Joana Batista de Castro Pinto e Tânia Maria Pereira de Pinho 
 
Por favor leia e assinale com uma cruz (X) os quadrados seguintes. 
Eu confirmo que percebi a informação que me foi dada e tive a oportunidade de questionar e 
de me esclarecer. 
 
Eu percebo que a participação do meu encarregando é voluntária e que ele é livre de desistir, 
em qualquer altura, sem dar nenhuma explicação, sem que isso afete qualquer serviço de 
educação ou saúde que lhe seja prestado. 
 
Eu compreendo que os dados recolhidos durante a investigação são confidenciais e que só os 
investigadores responsáveis pelo projeto têm acesso a eles. E dou portanto, autorização para 
que os mesmos tenham acesso a esta informação. 
 
Eu compreendo que os resultados do estudo serão publicados numa dissertação de mestrado 
e jornais e/ou conferências de finalidade científica sem que haja qualquer quebra de 
confidencialidade e anonimato. E dou portanto, autorização para a utilização dos dados para 
esses fins. 
 
Eu confirmo que o meu encarregando foi questionado acerca da sua vontade em participar 
no estudo e que nenhuma avaliação foi realizada contra a sua vontade, sendo assim 
respeitada a sua autonomia. 
 
Eu concordo então em participar no estudo.  
 
 
Assinatura do Participante 
 
 Encarregado de Educação 
 
 
 Data 
 
 
 Assinatura do Encarregado 
de Educação 
 
Investigador    Data  Assinatura 
 
